Articles dans des revues avec comité de lecture (373)
81.
Abeloos, L., Maris, C., Salmon, I., Balériaux, D., Sadeghi-Meibodi, N., & Lefranc, F. (2012). Chondroma of the dural convexity: A case report and literature review. Neuropathology, 32(3), 306-310. doi:10.1111/j.1440-1789.2011.01264.x82.
Ferdinande, L., Decaestecker, C., Verset, L., Mathieu, A., Moles Lopez, X., Negulescu, A., Van Maerken, T., Salmon, I., Cuvelier, C. A., & Demetter, P. (2012). Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer. British Journal of Cancer, 106(1), 141-147. doi:10.1038/bjc.2011.51383.
Marhfour, I., Moles Lopez, X., Lefkaditis, D., Salmon, I., Allagnat, F., Richardson, S. J., Morgan, N. G., & Eizirik, D. L. (2012). Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia, 55(9), 2417-2420. doi:10.1007/s00125-012-2604-384.
Huylebrouck, M., Lv, S., Duerinck, J., Van Binst, A., Salmon, I., De Greve, J., De Witte, O., Luce, S., Michotte, A., D'haens, J.-H., & Neyns, B. (2012). An observational study of the first experience with Bevacizumab for the treatment of patients with recurrent high-grade glioma in two belgian university hospitals. Journal of Oncology., 801306. doi:10.1155/2012/80130685.
Lv, S., Teugels, E., Sadones, J., Quartier, E., Huylebrouck, M., Du Four, S., Le Mercier, M., De Witte, O., Salmon, I., Michotte, A., De Greve, J., & Neyns, B. (2011). Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma. Anticancer research, 31(12), 4457-4463.86.
Norrenberg, S., Rorive, S., Laskar, P., Catteau, X., Delpierre, I., Avni, E., & Salmon, I. (2011). Acute transient thyroid swelling after fine-needle aspiration biopsy: rare complication of unknown origin. Clinical endocrinology, 75(4), 568-570. doi:10.1111/j.1365-2265.2011.04064.x87.
Devosse, T., Dutoit, R., Migeotte, I., De Nadai, P., Imbault, V., Communi, D., Salmon, I., & Parmentier, M. (2011). Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3. The Journal of immunology, 187(3), 1475-1485. doi:10.4049/jimmunol.100354589.
De Tiege, X., Van Bogaert, P., Aeby, A., Salmon, I., Parpal, H., Poppe, A. Y., Maris, C., & Lanthier, S. (2011). Primary angiitis of the central nervous system: neurologic deterioration despite treatment. Pediatrics, 127(4), 1086-1090. doi:10.1542/peds.2009-272990.
Marechal, R., Mackey, J. R., Lai, R., Demetter, P., Peeters, M., Polus, M., Cass, C. E., Salmon, I., Devière, J., & Van Laethem, J.-L. (2010). Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. Cancer, 116(22), 5200-5206. doi:10.1002/cncr.2530391.
Rorive, S., Moles Lopez, X., Maris, C., Trepant, A.-L., Sauvage, S., Sadeghi-Meibodi, N., Roland, I., Decaestecker, C., & Salmon, I. (2010). TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Modern pathology, 23(10), 1418-1428. doi:10.1038/modpathol.2010.13692.
Laurendeau, I., Ferrer, M., Garrido, D., D'Haene, N., Ciavarelli, P., Basso, A., Vidaud, M., Bièche, I., Salmon, I., & Szijan, I. (2010). Gene expression profiling of the hedgehog signaling pathway in human meningiomas. Molecular medicine, 16(7-8), 262-270. doi:10.2119/molmed.2010.00005